iBio Inc (IBIO)

[guay]

the Special Sauce Right Across the Street - $iBio

Okay wake up... FujiFilm Diosynth Biotechnologies has been selected to manufacture Novavax.

In our PR on April 9th Casper says this

“Combining iBio’s VLP antigen with an IDRI adjuvant provides for promising safety and efficacy characteristics, and importantly, the ready ability to scale-up manufacturing to help meet the projected global demand for a suitable vaccine.”

THEY ARE RIGHT ACROSS THE STREET.

Okay.

CASPER TALKS ADJUVANTS in the Novavax Article. On AUGUST 6th The Novavax vaccine requires an immune-boosting ingredient called an adjuvant to be effective.

npr.org/sections/health-shot 2020/08/06/899813217/the-special-sauce-that-makes-some-vaccines-work

TOM TWEETS THE SPECIAL SAUCE. On AUGUST 10th

WE ARE MANUFACTURING AND WORKING OUR ASSES OFF.

MANUFACTURING ADJUVANTS HELPING OUT ACROSS THE STREET

Source: https://stocktwits.com/ibio_bagholder23/message/236712099

https://www.wksu.org/post/special-sauce-makes-some-vaccines-work





Company Overview
iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.
#iBio $iBio iBio